AZTA vs LH: fair value comparison
Azenta, Inc. and Labcorp Holdings Inc. · Updated 2026-09-12
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, AZTA currently sits closer to the top of our discount ranking.
| AZTA | LH | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $31.57 | $311.54 |
| 12-month range | $21.18–$37.53 | $251.66–$327.61 |
| Sector rank | #84 of 113 Healthcare | #88 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Stable |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: AZTA fair value analysis · LH fair value analysis